Personalized Medicine Coalition
Daryl Pritchard serves as the Senior Vice President of Science Policy at the Personalized Medicine Coalition since August 2014, where leadership efforts focus on advancing personalized medicine through outreach, policy development, and advocacy. Prior experience includes directorial roles at the National Pharmaceutical Council overseeing policy research, at the Biotechnology Industry Organization advocating for personalized medicine and molecular diagnostics, and at the American Association for Dental Research managing legislative affairs. Early career roles include policy fellowships and research positions related to genetics and molecular oncology. Daryl Pritchard holds a Ph.D. and M.Phil. in Genetics from The George Washington University and a B.A. in Biological Sciences from the University of Delaware.
This person is not in any teams
This person is not in any offices
Personalized Medicine Coalition
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. Personalized medicine is an evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each patient. By combining the data from those tests with an individual’s medical history, circumstances and values, health care providers can develop targeted treatment and prevention plans. Recognizing that a paradigm shift in medicine will not happen just because the science suggests it should, the Coalition spearheads a robust portfolio of activities in education and advocacy, including the Annual Personalized Medicine Conference at Harvard Medical School.